EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Recro Pharma, Inc.:
We consent to the use of our report dated March 25, 2015 with respect to the balance sheets of Recro Pharma, Inc. as of December 31, 2013 and 2014, and the related statements of operations, redeemable convertible preferred stock and shareholders’ equity (deficit), and cash flows for the years then ended, incorporated herein by reference.
/s/ KPMG LLP
Philadelphia, Pennsylvania
August 11, 2015
